 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Conatus Pharmaceuticals Inc. (CNAT)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-18 Option Award | 2019-11-19 4:10 pm | N/A 2029-11-17 | Conatus Pharmaceuticals Inc. | CNAT | Scott Kathleen D. Director | 30,000 | $0.33 | 30,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2023-09-18 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 15,000 | $9.61 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2024-02-06 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 15,000 | $9.45 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2025-02-22 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 15,000 | $6.4 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2026-02-03 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 15,000 | $1.85 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2026-02-03 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 3,750 | $1.85 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2026-03-23 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 20,000 | $2.09 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2027-01-25 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 23,000 | $4.21 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 16,000 | $5.17 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 50,000 | $2 | 86,375 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-01 4:13 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 86,375 | $0 | 86,375 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2024-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 50,000 | $9.45 | 313,436 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2025-02-22 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 100,000 | $6.4 | 313,436 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2026-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 109,375 | $1.85 | 313,436 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2026-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 21,875 | $1.85 | 313,436 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2027-01-25 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 100,625 | $4.21 | 313,436 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 70,000 | $5.17 | 313,436 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:13 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 175,000 | $2 | 313,436 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-01 4:13 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 313,436 | $0 | 313,436 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:12 pm | N/A 2027-08-30 | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W CFO COO | 525,000 | $5.74 | 385,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:12 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W CFO COO | 70,000 | $5.17 | 385,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:12 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W CFO COO | 175,000 | $2 | 385,000 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-01 4:12 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W CFO COO | 385,000 | $0 | 385,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2024-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 400,000 | $9.45 | 650,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2025-02-22 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 150,000 | $6.4 | 650,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2025-02-22 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 50,000 | $6.4 | 650,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2026-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 20,000 | $1.85 | 650,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2026-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 37,500 | $1.85 | 650,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2027-01-25 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 172,500 | $4.21 | 650,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 120,000 | $5.17 | 650,000 (Direct) | View |
| 2019-08-01 Disposition | 2019-08-01 4:11 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 350,000 | $2 | 650,000 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-01 4:11 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 650,000 | $0 | 650,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:34 pm | N/A 2029-06-26 | Conatus Pharmaceuticals Inc. | CNAT | Van Wart Harold Director | 20,000 | $0.29 | 20,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:34 pm | N/A 2029-06-26 | Conatus Pharmaceuticals Inc. | CNAT | LARUE WILLIAM R Director | 20,000 | $0.29 | 20,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:33 pm | N/A 2029-06-26 | Conatus Pharmaceuticals Inc. | CNAT | Klassen Preston Director | 20,000 | $0.29 | 20,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:32 pm | N/A 2029-06-26 | Conatus Pharmaceuticals Inc. | CNAT | KISNER DANIEL L Director | 20,000 | $0.29 | 20,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 4:31 pm | N/A 2029-06-26 | Conatus Pharmaceuticals Inc. | CNAT | HALE DAVID F Director | 45,000 | $0.29 | 45,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:22 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 50,000 | $2 | 50,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:21 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 175,000 | $2 | 175,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:20 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Smith Edward F III VP | 4,690 | $3.31 | 100,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:20 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Smith Edward F III VP | 1,724 | $3.15 | 100,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:20 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Smith Edward F III VP | 100,000 | $2 | 100,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:19 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | RIPLEY DANIEL L. VP | 1,290 | $3.31 | 100,000 (Indirect) | View |
| 2019-02-07 Option Award | 2019-02-11 4:19 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | RIPLEY DANIEL L. VP | 1,861 | $3.15 | 100,000 (Indirect) | View |
| 2019-02-07 Option Award | 2019-02-11 4:19 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | RIPLEY DANIEL L. VP | 100,000 | $2 | 100,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:18 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W CFO COO | 175,000 | $2 | 175,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:15 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Hagerty David T VP | 175,000 | $2 | 175,000 (Direct) | View |
| 2019-02-07 Option Award | 2019-02-11 4:14 pm | N/A 2029-02-06 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 350,000 | $2 | 350,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:08 pm | N/A 2028-06-20 | Conatus Pharmaceuticals Inc. | CNAT | Van Wart Harold Director | 20,000 | $4.99 | 20,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:07 pm | N/A 2028-06-20 | Conatus Pharmaceuticals Inc. | CNAT | Scopa James Paul Director | 20,000 | $4.99 | 20,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:07 pm | N/A 2028-06-20 | Conatus Pharmaceuticals Inc. | CNAT | LARUE WILLIAM R Director | 20,000 | $4.99 | 20,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:06 pm | N/A 2028-06-20 | Conatus Pharmaceuticals Inc. | CNAT | Klassen Preston Director | 20,000 | $4.99 | 20,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:05 pm | N/A 2028-06-20 | Conatus Pharmaceuticals Inc. | CNAT | KISNER DANIEL L Director | 20,000 | $4.99 | 20,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:04 pm | N/A 2028-06-20 | Conatus Pharmaceuticals Inc. | CNAT | HALE DAVID F Director | 45,000 | $4.99 | 45,000 (Direct) | View |
| 2018-05-04 Exercise | 2018-05-07 7:46 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 60,000 | $0.99 | 147,070 (Direct) | View |
| 2018-05-04 Exercise | 2018-05-07 7:46 pm | 2011-02-17 2021-02-16 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 60,000 | $0.99 | 147,070 (Direct) | View |
| 2018-02-27 Exercise | 2018-03-01 4:08 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 12,121 | $1.24 | 0 (Direct) | View |
| 2018-02-27 Exercise | 2018-03-01 4:08 pm | 2008-03-03 2018-03-02 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 12,121 | $1.24 | 0 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 5:04 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | VANDERTIE MICHELLE L VP | 16,000 | $5.17 | 16,000 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 5:03 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Spada Alfred P. EVP R&D and CSO | 70,000 | $5.17 | 70,000 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 5:03 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | Smith Edward F III VP | 4,461 | $3.48 | 40,000 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 5:03 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Smith Edward F III VP | 40,000 | $5.17 | 40,000 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 5:02 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | RIPLEY DANIEL L. VP | 761 | $1.7 | 40,000 (Indirect) | View |
| 2018-02-04 Option Award | 2018-02-05 5:02 pm | N/A N/A | Conatus Pharmaceuticals Inc. | CNAT | RIPLEY DANIEL L. VP | 818 | $3.48 | 40,000 (Indirect) | View |
| 2018-02-04 Option Award | 2018-02-05 5:02 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | RIPLEY DANIEL L. VP | 40,000 | $5.17 | 40,000 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 5:00 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W CFO COO | 70,000 | $5.17 | 70,000 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 4:59 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Hagerty David T VP | 70,000 | $5.17 | 70,000 (Direct) | View |
| 2018-02-04 Option Award | 2018-02-05 4:57 pm | N/A 2028-02-03 | Conatus Pharmaceuticals Inc. | CNAT | Mento Steven J CEO | 120,000 | $5.17 | 120,000 (Direct) | View |
| 2017-08-31 Option Award | 2017-09-01 4:14 pm | N/A 2027-08-30 | Conatus Pharmaceuticals Inc. | CNAT | Marshall Keith W CFO COO | 525,000 | $5.74 | 525,000 (Direct) | View |
| 2017-06-22 Option Award | 2017-06-26 4:16 pm | N/A 2027-06-21 | Conatus Pharmaceuticals Inc. | CNAT | Scopa James Paul Director | 20,000 | $4.96 | 20,000 (Direct) | View |
| 2017-06-22 Option Award | 2017-06-26 4:16 pm | N/A 2027-06-21 | Conatus Pharmaceuticals Inc. | CNAT | Klassen Preston Director | 20,000 | $4.96 | 20,000 (Direct) | View |
| 2017-06-22 Option Award | 2017-06-26 4:15 pm | N/A 2027-06-21 | Conatus Pharmaceuticals Inc. | CNAT | KISNER DANIEL L Director | 20,000 | $4.96 | 20,000 (Direct) | View |
| 2017-06-22 Option Award | 2017-06-26 4:14 pm | N/A 2027-06-21 | Conatus Pharmaceuticals Inc. | CNAT | Van Wart Harold Director | 20,000 | $4.96 | 20,000 (Direct) | View |
| 2017-06-22 Option Award | 2017-06-26 4:12 pm | N/A 2027-06-21 | Conatus Pharmaceuticals Inc. | CNAT | HALE DAVID F Director | 45,000 | $4.96 | 45,000 (Direct) | View |
| 2017-02-06 Option Award | 2017-02-07 8:23 pm | N/A 2027-02-05 | Conatus Pharmaceuticals Inc. | CNAT | LARUE WILLIAM R Director | 30,000 | $5.09 | 30,000 (Direct) | View |
| 2017-01-26 Option Award | 2017-02-02 4:29 pm | N/A 2027-01-25 | Conatus Pharmaceuticals Inc. | CNAT | RIPLEY DANIEL L. VP | 73,000 | $4.21 | 73,000 (Direct) | View |